Showing results (71-80 of 192) with videos related to
Sort By:
Pageof 20
Scientific Reports|May 4, 2021
Machine learning applied to near-infrared spectra for clinical pleural effusion classificationZhongjian Chen, Keke Chen, Yan Lou, et al.Lung Cancer (Amsterdam, Netherlands)|March 25, 2018
Clinicopathological characteristics of POLE mutation in patients with non-small-cell lung cancerZhengbo Song, Guoping Cheng, Chunwei Xu, et al.Medical Oncology (Northwood, London, England)|June 9, 2023
Comparison of the immunotherapy efficacy between invasive mucinous and non-mucinous adenocarcinoma in advanced lung cancer patients with KRAS mutation: a retrospective studyManyi Xu, Yue Hao, Huan Zhou, et al.Cancer Medicine|June 12, 2023
Comparison of efficacy and safety of second- and third-generation TKIs for non-small-cell lung cancer with uncommon EGFR mutationsYue Hao, Manyi Xu, Jianan Jin, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 16, 2024
Exploration of efficacy of different therapy regimens for advanced NSCLC patients with KRAS mutation in the first-line treatmentKe Wang, Manyi Xu, Yanhua Wang, et al.Journal of Thoracic Disease|July 13, 2018
The correlation between crizotinib efficacy and molecular heterogeneity by next-generation sequencing in non-small cell lung cancerTangfeng Lv, Qian Zou, Zhengbo Song, et al.Medical Oncology (Northwood, London, England)|June 26, 2013
Correlation of EGFR mutation and predominant histologic subtype according to the new lung adenocarcinoma classification in Chinese patientsZhengbo Song, Huineng Zhu, Zhenying Guo, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 24, 2024
Rechallenge immunotherapy after immune resistance in patients with advanced thymic carcinomaKeda Shao, Xiaohong Zeng, Yue Hao, et al.Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|August 3, 2010
[Safety analysis of ambulatory chemotherapy in lung cancer]Yun Feng, Shun Lu, Zhengbo Song, et al.Journal of Thoracic Disease|June 18, 2025
Efficacy evaluation of tyrosine kinase inhibitors for advanced non-small cell lung cancer patients with leptomeningeal metastasisYanhua Wang, Yue Hao, Manyi Xu, et al.Pageof 20